Free Trial

Jefferies Financial Group Upgrades Enhabit (NYSE:EHAB) to Buy

Enhabit logo with Medical background

Jefferies Financial Group upgraded shares of Enhabit (NYSE:EHAB - Free Report) from a hold rating to a buy rating in a research report report published on Monday morning, Marketbeat.com reports. Jefferies Financial Group currently has $9.50 target price on the stock, up from their prior target price of $8.25.

Separately, Leerink Partners restated a "market perform" rating and set a $8.00 price target (down from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One equities research analyst has rated the stock with a sell rating, five have given a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, Enhabit presently has an average rating of "Hold" and a consensus price target of $9.40.

Check Out Our Latest Stock Analysis on EHAB

Enhabit Price Performance

Shares of NYSE:EHAB traded up $1.01 during midday trading on Monday, reaching $8.75. 713,747 shares of the company's stock traded hands, compared to its average volume of 576,079. The company has a fifty day simple moving average of $7.46 and a two-hundred day simple moving average of $8.31. Enhabit has a 1 year low of $6.85 and a 1 year high of $11.74. The company has a market cap of $439.70 million, a P/E ratio of -3.33 and a beta of 1.89. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.

Enhabit (NYSE:EHAB - Get Free Report) last announced its earnings results on Wednesday, November 6th. The company reported $0.03 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The company had revenue of $253.60 million during the quarter, compared to analyst estimates of $261.69 million. During the same quarter last year, the business earned $0.03 EPS. Equities analysts predict that Enhabit will post 0.22 EPS for the current fiscal year.

Institutional Investors Weigh In On Enhabit

A number of institutional investors have recently modified their holdings of the company. FMR LLC increased its holdings in Enhabit by 138.4% during the 3rd quarter. FMR LLC now owns 3,388 shares of the company's stock worth $27,000 after purchasing an additional 1,967 shares during the period. Gladius Capital Management LP acquired a new stake in Enhabit in the second quarter valued at approximately $31,000. Quarry LP lifted its stake in Enhabit by 242.2% in the second quarter. Quarry LP now owns 3,703 shares of the company's stock worth $33,000 after acquiring an additional 2,621 shares during the last quarter. Stoneridge Investment Partners LLC acquired a new position in Enhabit during the 3rd quarter worth approximately $81,000. Finally, Canada Pension Plan Investment Board purchased a new stake in shares of Enhabit in the 2nd quarter valued at approximately $93,000.

About Enhabit

(Get Free Report)

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.

Featured Stories

Analyst Recommendations for Enhabit (NYSE:EHAB)

Should you invest $1,000 in Enhabit right now?

Before you consider Enhabit, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enhabit wasn't on the list.

While Enhabit currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

These 7 Stocks Will Be Magnificent in 2025 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Broadcom Hits $1 Trillion – Can This AI Powerhouse Go Higher?
SoundHound Stock Explodes Again – Is a Major Breakout Coming?
How Fintech Strategy at FinWise Bancorp and CEO Vision Are Driving 78% Gains

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines